Europe Heart Failure Poc & Loc Devices Market Size & Outlook

The heart failure poc & loc devices market in Europe is expected to reach a projected revenue of US$ 77.2 million by 2030. A compound annual growth rate of 16.4% is expected of Europe heart failure poc & loc devices market from 2025 to 2030.
Revenue, 2024 (US$M)
$31.9
Forecast, 2030 (US$M)
$77.2
CAGR, 2025 - 2030
16.4%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe heart failure poc & loc devices market, 2018-2030 (US$M)

Europe heart failure poc & loc devices market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Europe heart failure poc & loc devices market highlights

  • The Europe heart failure poc & loc devices market generated a revenue of USD 31.9 million in 2024.
  • The market is expected to grow at a CAGR of 16.4% from 2025 to 2030.
  • In terms of segment, proteomic testing was the largest revenue generating test type in 2024.
  • Metabolomic Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.

Europe data book summary

Market revenue in 2024USD 31.9 million
Market revenue in 2030USD 77.2 million
Growth rate16.4% (CAGR from 2025 to 2030)
Largest segmentProteomic testing
Fastest growing segmentMetabolomic Testing
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProteomic Testing, Metabolomic Testing, Genomic Testing
Key market players worldwideAbbott Laboratories, Danaher Corp, Siemens Healthineers AG ADR, QuidelOrtho Corp, BioMerieux SA, Trinity Biotech PLC ADR, Abaxis, Roche Holding AG

Other key industry trends

  • In terms of revenue, Europe region accounted for 31.2% of the global heart failure poc & loc devices market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 32.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Heart Failure POC & LOC Devices Market Companies

Name Profile # Employees HQ Website
Abaxis View profile 5001-10000 Union City, California, United States, North America http://abaxis.com
Trinity Biotech PLC ADR View profile 380 IDA Business Park, Bray, County Wicklow, Dublin, Ireland, A98 H5C8 https://www.trinitybiotech.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Europe heart failure poc & loc devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart failure poc & loc devices market will help companies and investors design strategic landscapes.


Proteomic testing was the largest segment with a revenue share of 57.68% in 2024. Horizon Databook has segmented the Europe heart failure poc & loc devices market based on proteomic testing, metabolomic testing, genomic testing covering the revenue growth of each sub-segment from 2018 to 2030.


Adoption of POC testing in hospital settings is continuously increasing across European countries. However, its usage is not high as in the U.S. A number of efforts by key stakeholders in the market to drive adoption of POC & LOC devices in the region are anticipated to boost revenue growth.

In June 2019, a conference titled “Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019” was hosted by the Netherlands. This annual conference involved a discussion about the expanding POC tests and wearables, including microfluidics-based and LOC approaches, from innovative technologies to regulatory approval.

Furthermore, the European Society of Cardiology (ESC), involved in improving management of acute and chronic heart failure, is one of the key contributors in the Europe market. In 2016, ESC published guidelines regarding the diagnosis and treatment of chronic and acute heart failure in the region.

Reasons to subscribe to Europe heart failure poc & loc devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe heart failure poc & loc devices market databook

  • Our clientele includes a mix of heart failure poc & loc devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe heart failure poc & loc devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe heart failure poc & loc devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe heart failure poc loc devices market size, by country, 2018-2030 (US$M)

Europe Heart Failure POC & LOC Devices Market Outlook Share, 2024 & 2030 (US$M)

Europe heart failure poc loc devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online